- Home
- COCP vs TRIB Comparison
COCP vs TRIB Comparison
Compare COCP & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- TRIB
- Stock Information
- Founded
- COCP 2006
- TRIB 1992
- Country
- COCP United States
- TRIB Ireland
- Employees
- COCP N/A
- TRIB N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- COCP Health Care
- TRIB Health Care
- Exchange
- COCP Nasdaq
- TRIB Nasdaq
- Market Cap
- COCP 15.4M
- TRIB 14.0M
- IPO Year
- COCP N/A
- TRIB N/A
- Fundamental
- Price
- COCP $1.60
- TRIB $0.83
- Analyst Decision
- COCP Strong Buy
- TRIB
- Analyst Count
- COCP 1
- TRIB 0
- Target Price
- COCP $6.00
- TRIB N/A
- AVG Volume (30 Days)
- COCP 169.4K
- TRIB 207.2K
- Earning Date
- COCP 08-22-2025
- TRIB 08-19-2025
- Dividend Yield
- COCP N/A
- TRIB N/A
- EPS Growth
- COCP N/A
- TRIB N/A
- EPS
- COCP N/A
- TRIB N/A
- Revenue
- COCP N/A
- TRIB $61,555,000.00
- Revenue This Year
- COCP N/A
- TRIB $13.51
- Revenue Next Year
- COCP N/A
- TRIB $13.14
- P/E Ratio
- COCP N/A
- TRIB N/A
- Revenue Growth
- COCP N/A
- TRIB 8.31
- 52 Week Low
- COCP $1.12
- TRIB $0.48
- 52 Week High
- COCP $3.26
- TRIB $3.39
- Technical
- Relative Strength Index (RSI)
- COCP 46.18
- TRIB 57.44
- Support Level
- COCP $1.56
- TRIB $0.66
- Resistance Level
- COCP $2.19
- TRIB $0.93
- Average True Range (ATR)
- COCP 0.14
- TRIB 0.06
- MACD
- COCP -0.02
- TRIB 0.02
- Stochastic Oscillator
- COCP 6.35
- TRIB 66.69
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.